Literature DB >> 8833733

High-intensity focused ultrasound ablation of rabbit kidney tumors.

J B Adams1, R G Moore, J H Anderson, J D Strandberg, F F Marshall, L R Davoussi.   

Abstract

High-intensity focused ultrasound (HIFU) is a noninvasive surgical technique in which ultrasound energy is delivered transcutaneously to a discrete area within the body. This energy can result in a well-defined zone of cellular death within the targeted tissue. We used HIFU in an effort to ablate rabbit VX-2 kidney tumors. A tumor cell suspension was injected into a renal segmental artery (Phase 1, nine rabbits) or directly into the lower pole parenchyma (Phase 2, nine rabbits). After a 2-week incubation period, open direct contact (Phase 1) or transcutaneous ablation (Phase 2) was performed. In Phase 1, after sonablation, there was pathologic evidence of tissue destruction in nine animals, and seven had both gross and histologic evidence of tumor ablation. There was sharp demarcation between viable and ablated tissue. In Phase 2, pathologic evidence of kidney ablation was seen in seven of nine animals. However, only two rabbits showed the well-demarcated effects of ablation in the tumor. High-intensity focused ultrasound can be effective at causing cell death in renal tumors and surrounding renal tissue. However, with the present ultrasound technology, imaging of renal lesions in the rabbit model is not adequate to consistently localize and completely ablate tumor.

Entities:  

Mesh:

Year:  1996        PMID: 8833733     DOI: 10.1089/end.1996.10.71

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  12 in total

1.  Analysis of clinical effect of high-intensity focused ultrasound on liver cancer.

Authors:  Chuan-Xing Li; Guo-Liang Xu; Zhen-You Jiang; Jian-Jun Li; Guang-Yu Luo; Hong-Bo Shan; Rong Zhang; Yin Li
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

2.  Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors.

Authors:  Jian-Jun Li; Guo-Liang Xu; Mo-Fa Gu; Guang-Yu Luo; Zhang Rong; Pei-Hong Wu; Jian-Chuan Xia
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

3.  Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.

Authors:  Kent Perry; Amnon Zisman; Allan J Pantuck; Nicolette Janzen; Peter Schulam; Arie S Belldegrun
Journal:  Rev Urol       Date:  2002

4.  Growth inhibition of high-intensity focused ultrasound on hepatic cancer in vivo.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Yan-Rong Lu; Jie Zhang; Bo-Tao Liu; Wen-Fu Zeng; Yue-Ming He; Yu-Rui Fu
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

5.  High intensity focused ultrasound treatment of small renal masses: Clinical effectiveness and technological advances.

Authors:  G Nabi; C Goodman; A Melzer
Journal:  Indian J Urol       Date:  2010-07

6.  [HIFU in urological oncology].

Authors:  S Thüroff; C Chaussy
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

Review 7.  [Energy ablative therapy of renal tumours].

Authors:  H C Klingler
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

Review 8.  [Transrectal high-intensity focused ultrasound for local treatment of prostate cancer. 2009 Update].

Authors:  C G Chaussy; S Thüroff
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

Review 9.  Minimally invasive ablative approaches in the treatment of renal cell carcinoma.

Authors:  Nicolette Janzen; Amnon Zisman; Allan J Pantuck; Kent Perry; Peter Schulam; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

Review 10.  Update on minimally invasive approaches to kidney tumors.

Authors:  Jonathan J Hwang; McClellan M Walther
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.